Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Abstract

Survivin demonstrates a strong, independent, association with poor prognosis. Survivin might be used as a new marker to stratify breast cancer patients for more optimal treatment modalities, or it could be a promising new target for therapy.